Narrow Your Search

Narrow Your Search

Focus

Companies

People

News

9,184 News Articles
Mar
05
2024

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

Andrew Jacobs, who writes about psychedelic medicine, reported from Louisville, Ky. March 5, 2024. Ibogaine, a formidable hallucinogen made from the ...
Mar
05
2024

When it comes to ketamine, Meta's posting policy is no party to decipher - CBS News

Thus, ketamine is the latest challenge for Meta, the social media platforms' parent company, which for years has struggled to moderate posts and ads ...
Mar
05
2024

Psilocybin Poison Control Calls Spike in Teens, Young Adults - Medscape

Calls regarding psilocybin to poison control centers tripled in teens and doubled in young adults in recent years, coinciding with ...
Mar
05
2024

Brazen Drug Ads Wreak Havoc Thanks to Meta's Facebook Ad Algorithms | High Times

It's open season for flagrant ads to sell illegal drugs like psilocybin, LSD, and other drugs, as Meta works to improve its algorithms to filter ...
Mar
05
2024

NY Ketamine Infusions Launches Groundbreaking Ketamine Treatment Program for Alcohol ...

Ketamine, a medication known for its anesthetic properties, has shown remarkable promise in treating alcohol dependence by targeting the underlying ...
Ketamine
Mar
05
2024

What to Know About Ibogaine, a Psychedelic - The New York Times

Some researchers hope the drug, still illegal in the United States, may be considered as a treatment for addiction, PTSD and brain injuries.
Mar
05
2024

AMA with Ceo of MDMA | Pharmala Biotech Holdings Inc - Stockhouse

CSE:MDMA Forum Post by Firepoker-35915015: Nick (Ceo of MDMA) came on CEO board to state, he will be doing an AMA on Fri 5pm...if you have ...
MDMA
Mar
05
2024

'Magic Mushrooms' Fight Depression Better Than Normal Medication, Study Suggests

... psilocybin, the main compound of the drug that causes psychedelic trips, could hold the key to treating mental-health issues such as treatment ...
Mar
04
2024

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

... (DMT). ADVERTISEMENT. Advertisement. The Phase 1b study is designed to evaluate the relative safety, tolerability, pharmacokinetics (PK) and ...
Mar
04
2024

atai Biotech Launches Phase 1b Trial for Innovative DMT Formulation VLS-01, Targets ...

Discover atai Life Sciences' Phase 1b trial of VLS-01, a novel DMT formulation aiming to transform treatment for resistant depression.
DMT
Mar
04
2024

Marketing magic: How influencers are helping sell psychedelics to social media masses

The adoption of influencer marketing in psychedelics was inevitable, according to Ricardo Baca, founder and CEO of the Grasslands marketing agency, ...
Mar
04
2024

Low-Dose Ketamine Improves Depression Symptoms: Study Findings - Bollyinside

Common anesthetic in low doses can improve symptoms of depression, As mentioned in a recent study. Ketamine is often used at low doses to treat.
Ketamine
Mar
01
2024

Northwestern Medicine Study Unveils Ketamine's Dual Impact on Depression

Unlike traditional antidepressants that may take weeks to take effect, ketamine provides immediate relief while also offering sustained benefits, a ...
Mar
01
2024

Denver officials want to get ahead of regulation for magic mushrooms - YouTube

... psychedelic mushrooms under supervision ... Paul Stamets on the Future of Psychedelics, Mycology & Medicine | NextMed Health.
Mar
01
2024

Study Uncovers How Ketamine Works Both Rapidly and Long-Term | Technology Networks

Ketamine accomplishes this, but toxic side effects limit its long-term use. Scientists haven't understood how ketamine was able to do both, which ...
Ketamine
Mar
01
2024

Wonderland Miami 2023 Focuses On Practical Psychedelic Business Updates, Marvels

The event featured more than 250 speakers, 60 exhibitors and close to 5,000 attendees diving deep into the functionality of various psychedelics and..
Mar
01
2024

Expanding Mindscapes: A Global History of Psychedelics - Isthmus | Madison, Wisconsin

UW Center for the Humanities Borghesi-Mellon Psychedelic Pasts, Presents, and Futures Workshop talk by Erika Dyck, Room 126.
Psychedelics
Feb
29
2024

Letter: Psilocybin use deserves consideration - The Portland Press Herald

The bill would regulate the safe and therapeutic use of psychedelic medicine for adults over age 21. It would create a psilocybin advisory board that ...
Psilocybin
Feb
29
2024

Incannex riding high on psilocybin's large clinical effect in anxiety - The Pharma Letter

This followed the Australia-based company's announcement of positive toline results from its Phase II Psi-GAD1 trial of psilocybin in generalized ...
Feb
29
2024

Quest for insurance coverage of Ketamine therapy, considered by Hawaii legislators

From homeless people to the affluent and several in between, depression and suicide cases have been on the rise in parts of Hawaii in recent years ...
Ketamine
Feb
29
2024

Elon Musk's Mental Health Discourse: Therapy Stance Amidst Personal Struggles

Explore Elon Musk's public statements on therapy, microdosing ketamine, and their implications for mental health discourse in the tech industry ...
Feb
29
2024

In Oregon, psilocybin treatment is an experiment in real time - OPB

Though the clients of these centers don't have to have a mental illness or medical referral, the promise psilocybin had shown in studies to treat ...
Feb
29
2024

Psilocybin and the Development of Serotonin Toxicity - Psychiatrist.com

Psilocybin is a serotonergic and dopaminergic psychedelic that has gained recognition in the potential to mitigate symptoms of major depressive ...
Psilocybin
Feb
29
2024

Psychedelics as Medicine: Long-Term Effects Overview - HealthNews

Psychedelics include drugs like psilocybin (magic mushrooms), lysergic acid (LSD or acid), ketamine, and DMT, the active chemical in ayahuasca.
Psychedelics
Feb
29
2024

Limited use of psilocybin, MDMA in Utah could be allowed under new bill - YouTube

Limited use of psilocybin, MDMA in Utah could be allowed under new bill. 24 views · 33 minutes ago ...more. FOX 13 News Utah. 284K.
MDMA LSD
Feb
29
2024

ACME Screening Room presents film, talk on psychedelic medicines

... psychedelic medicines. They will answer your questions about the benefits and status of these medicines, including options currently available in ...
Feb
29
2024

IV Solution & Ketamine Centers of Chicago Revolutionizes Healing for Ptsd Patients

Chicago, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Chicago, Illinois - The spotlight has recently been shining on IV Solution & Ketamine Centers of ...
Ketamine
Feb
29
2024

Red Light Holland Reports Third Quarter 2024 Results and Reminder to Shareholders of the ...

... psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, announces that it has ...
Feb
29
2024

Exploring the Efficacy of Ketamine as an Anesthetic and Antidepressant in Postpartum ... - Cureus

While traditional treatments for postpartum depression include therapy and medication, recent studies have shown promising results using ketamine. We ...
Ketamine
Feb
29
2024

Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility

Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a ...
Psilocybin
Feb
29
2024

Australia Is Leading The Charge For Psychedelic Anxiety Treatments But It's Not As Fun As It Sounds

Australian Dr Paul Liknaitzky and his lab at Clinical Psychedelic Lab, Monash University are leading the charge using psilocybin — the active ...
Feb
29
2024

Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights

... psilocybin treatment within various care settings, if approved by the FDA. We are also excited to provide a full data set from our phase 2 study ...
Feb
29
2024

Compass Pathways Reports Widening Loss in 2023, Ramps Up Investment in Psilocybin ...

The company, a pioneer in mental health care innovation, is focused on developing a new model of psilocybin therapy for treatment-resistant ...
Psilocybin
Feb
29
2024

Incannex's Psilocybin Clears Phase II Trial in Generalized Anxiety Disorder | BioSpace

Psilocybin is a psychedelic drug that works by activating serotonin type 2A receptors to induce a hallucinatory effect, which in turn can help counter ...
Psilocybin
Feb
28
2024

Research: Fact check: What LSD microdosing is all about - indonewyork

The following generally applies to LSD: The European Monitoring Center for Drugs and Drug Addiction (EMCDDA) does not see any risk of becoming ...
LSD
Feb
28
2024

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic ...

Ketamine is a racemic mixture of (R)-ketamine (arketamine) and (S)-ketamine (esketamine) (Fig. 1). Esketamine shows a higher affinity for the N-methyl ...
Ketamine